Programmed Cell Death 4 and MicroRNA 21 Inverse Expression Is Maintained in Cells and Exosomes From Ovarian Serous Carcinoma Effusions

被引:112
|
作者
Cappellesso, Rocco [1 ]
Tinazzi, Andrea [1 ]
Giurici, Thomas [1 ]
Simonato, Francesca [1 ]
Guzzardo, Vincenza [1 ]
Ventura, Laura [2 ]
Crescenzi, Marika [3 ]
Chiarelli, Silvia [1 ]
Fassina, Ambrogio [1 ]
机构
[1] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, I-35121 Padua, Italy
[2] Univ Padua, Dept Stat Sci, I-35121 Padua, Italy
[3] Ist Oncol Veneto IRCCS, Radiotherapy Unit, Padua, Italy
关键词
ovarian carcinoma; microRNA-21 (miR-21); programmed cell death 4 (PDCD4); exosomes; malignant effusions; NEOADJUVANT CHEMOTHERAPY; CANCER CELLS; TRANSFORMATION SUPPRESSOR; PRIMARY SURGERY; PDCD4; PROTEIN; IV; CHEMOSENSITIVITY; TRANSITION;
D O I
10.1002/cncy.21442
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Ovarian serous carcinoma (OSC) is a fatal gynecologic malignancy usually presenting with bilateral localization and malignant peritoneal effusion. Programmed cell death 4 (PDCD4) is a tumor suppressor gene whose expression is directly controlled by microRNA-21 (miR-21). Exosomes are small cell-derived vesicles that participate in intercellular communication, delivering their cargo of molecules to specific cells. Exosomes are involved in several physiological and pathological processes including oncogenesis, immunomodulation, angiogenesis, and metastasis. The current study analyzed the expression of PDCD4 and miR-21 in resected OSC specimens and in cells and exosomes from OSC peritoneal effusions. METHODS: PDCD4 was immunohistochemically examined in 14 normal ovaries, 14 serous cystadenoma (CA), and 14 OSC cases. Quantitative reverse transcriptase-polymerase chain reaction analysis of PDCD4 and miR-21 expression was performed in CA and OSC cases and in cells and exosomes obtained from 10 OSC and 10 nonneoplastic peritoneal effusions. miR-21 was also evaluated by in situ hybridization. RESULTS: Immunohistochemistry demonstrated a gradual PDCD4 loss from normal ovaries to CA and OSC specimens. Quantitative reverse transcriptase-polymerase chain reaction displayed higher PDCD4 messenger RNA levels in CA specimens compared with OSC cases and highlighted miR-21 overexpression in OSC specimens. In situ hybridization detected miR-21 only in OSC cells. This PDCD4 and miR-21 inverse expression was also noted in cells and exosomes from OSC peritoneal effusions compared with nonneoplastic effusions. CONCLUSIONS: PDCD4 and miR-21 are involved in OSC oncogenesis. The transfer of miR-21 by exosomes could promote oncogenic transformation in target cells distant from the primary tumor without direct colonization by cancer cells and could be used as a diagnostic tool. (C) 2014 American Cancer Society.
引用
收藏
页码:685 / 693
页数:9
相关论文
共 50 条
  • [41] MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas
    Wang, Yu-Quan
    Guo, Ren-De
    Guo, Rui-Meng
    Sheng, Wei
    Yin, Li-Rong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (07) : 1464 - 1473
  • [42] Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients
    Gallagher, Michael F.
    Flavin, Richard J.
    Elbaruni, Salah A.
    McInerney, Jamie K.
    Smyth, Paul C.
    Salley, Yvonne M.
    Vencken, Sebastian F.
    O'Toole, Sharon A.
    Laios, Alexandros
    Lee, Mathia Y. C.
    Denning, Karen
    Li, Jinghuan
    Aherne, Sinead T.
    Lao, Kai Q.
    Martin, Cara M.
    Sheils, Orla M.
    O'Leary, John J.
    JOURNAL OF OVARIAN RESEARCH, 2009, 2 (01)
  • [43] Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients
    Michael F Gallagher
    Richard J Flavin
    Salah A Elbaruni
    Jamie K McInerney
    Paul C Smyth
    Yvonne M Salley
    Sebastian F Vencken
    Sharon A O'Toole
    Alexandros Laios
    Mathia YC Lee
    Karen Denning
    Jinghuan Li
    Sinead T Aherne
    Kai Q Lao
    Cara M Martin
    Orla M Sheils
    John J O'Leary
    Journal of Ovarian Research, 2
  • [44] Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells
    Zhang, Shuhong
    Li, Jianfeng
    Jiang, Ying
    Xu, Yijun
    Qin, Chengyong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [45] Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells
    Shuhong Zhang
    Jianfeng Li
    Ying Jiang
    Yijun Xu
    Chengyong Qin
    Journal of Experimental & Clinical Cancer Research, 28
  • [46] Expression of programmed cell death - ligand 1 in Thai epithelial ovarian/fallopian tube/primary peritoneal carcinoma patients
    Tankul, Achjima
    Ruengkhachorn, Irene
    Hanamornroongruang, Suchanan
    Poungvarin, Naravat
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 190 - 191
  • [47] MicroRNA-503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4
    Shuang, Yu
    Zhou, Xuan
    Li, Chao
    Huang, Yongwang
    Zhang, Lun
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5249 - 5256
  • [48] Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma
    Patricia P Reis
    Miranda Tomenson
    Nilva K Cervigne
    Jerry Machado
    Igor Jurisica
    Melania Pintilie
    Mahadeo A Sukhai
    Bayardo Perez-Ordonez
    Reidar Grénman
    Ralph W Gilbert
    Patrick J Gullane
    Jonathan C Irish
    Suzanne Kamel-Reid
    Molecular Cancer, 9
  • [49] Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma
    Reis, Patricia P.
    Tomenson, Miranda
    Cervigne, Nilva K.
    Machado, Jerry
    Jurisica, Igor
    Pintilie, Melania
    Sukhai, Mahadeo A.
    Perez-Ordonez, Bayardo
    Grenman, Reidar
    Gilbert, Ralph W.
    Gullane, Patrick J.
    Irish, Jonathan C.
    Kamel-Reid, Suzanne
    MOLECULAR CANCER, 2010, 9
  • [50] Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
    Yuan, Yuan
    Nymoen, Dag Andre
    Dong, Hiep Phuc
    Bjorang, Ola
    Shih, Ie-Ming
    Low, Philip S.
    Trope, Claes G.
    Davidson, Ben
    HUMAN PATHOLOGY, 2009, 40 (10) : 1453 - 1460